Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ambient temperature variations and antimicrobial resistance: a multicountry analysis of non-linear relationships and temperature thresholds.

BMJ global health·2026
Same author

A Multi-Regional Single-nucleus Atlas of the Huntington's Disease Brain.

Scientific data·2026
Same author

Long-Term Exposure to Ambient Air Pollution and Prevalence of Infertility.

Environmental science & technology·2026
Same author

Distinctive respiratory toxicity induced by hypoxanthine metabolic disorder from polystyrene microplastics and nanoplastics at environmentally relevant doses: multi-omics insights and experimental validation.

Environment international·2026
Same author

CircRNA0052011 modulates DNA damage and repair via FEN1 ubiquitination to mitigate polystyrene nanoplastics-induced genotoxicity in the lung.

Environment international·2026
Same author

Global Spatiotemporal Variation and Death Burden of Compound Heatwave and Ozone Pollution Events.

Environmental science & technology·2026

Related Experiment Video

Updated: Sep 10, 2025

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

394

Ambient PM1 on COPD mortality: insights from a population-based study.

Wenfeng Lu1, Hong Sun2, Ruijun Xu3

  • 1Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou, Guangdong, China.

Journal of Epidemiology and Community Health
|August 27, 2025
PubMed
Summary

Short-term exposure to fine particulate matter (PM1) significantly increases the risk of death from chronic obstructive pulmonary disease (COPD). Reducing PM1 concentrations is crucial for public health, especially for individuals with COPD.

Keywords:
AIR POLLUTIONENVIRONMENTAL HEALTHEPIDEMIOLOGYMORTALITYPUBLIC HEALTH

More Related Videos

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.5K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

897

Related Experiment Videos

Last Updated: Sep 10, 2025

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

394
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.5K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

897

Area of Science:

  • Environmental Health
  • Respiratory Medicine
  • Epidemiology

Background:

  • Limited evidence exists on the short-term effects of fine particulate matter (PM1) on chronic obstructive pulmonary disease (COPD) mortality.
  • This study investigates the association between PM1 exposure and COPD mortality.

Purpose of the Study:

  • To explore the potential effects of PM1 exposure on COPD mortality.
  • To evaluate the exposure-response relationships and identify potential effect modifiers.

Main Methods:

  • A province-wide time-stratified case-crossover study was conducted in 13 cities in China from 2015 to 2019.
  • Daily mortality data and individual-level PM1 exposure estimates were analyzed using conditional logistic regression.
  • Exposure-response curves and effect modification were investigated.

Main Results:

  • A 10 μg/m³ increase in PM1 was associated with a 3.32% increase in COPD mortality risk.
  • PM1 showed stronger associations with COPD mortality compared to PM2.5.
  • Population attributable fractions for PM1-related mortality were substantial, ranging from 8.25% to 8.86%.

Conclusions:

  • Short-term exposure to PM1 is significantly associated with increased COPD mortality.
  • PM1 plays a predominant role within PM2.5, highlighting the need for targeted reduction strategies.
  • Findings underscore the importance of controlling PM1 for mitigating COPD-related deaths.